Clinical trials

  • NAVTEMADLIN for Primary myelofibrosis | Post-polycythemia vera myelofibrosis | Post-essential thrombocythemia myelofibrosis
  • Methotrexate for Erosive hand osteoarthritis | Hand osteoarthritis
  • rapcabtagene autoleucel for Non-active progressive multiple sclerosis (PMS) | Secondary progressive multiple sclerosis | Primary progressive multiple sclerosis
  • ODRONEXTAMAB for Relapsed and refractory B-cell non-Hodgkin lymphoma
  • AMIKACIN SULFATE for Sepsis | Neutropenia
  • TOVORAFENIB for Low-grade glioma | Advanced solid tumor
  • OATD-02 for Colorectal cancer | Ovarian cancer | Pancreatic cancer | Renal cell carcinoma
  • LENACAPAVIR, ISLATRAVIR for HIV-1 infection
  • RELACORILANT for Platinum-resistant high-grade epithelial ovarian cancer | Primary peritoneal cancer | Fallopian tube cancer
  • LECANEMAB for Mild cognitive impairment due to Alzheimer's disease | Alzheimer's disease dementia (mild)
  • TEMOZOLOMIDE for Well-differentiated neuroendocrine neoplasm (NEN) | Gastroenteropancreatic neuroendocrine tumor (GEP-NEN) | Bronchial carcinoid
  • ELRANATAMAB for Multiple myeloma